<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_ATOMS-Turkiye_Project_Future_Plan skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:ATOMS-Turkiye/Project/Future Plan</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="headerWrapper" class="hidden-xs hidden-sm"><DIV id="header"><DIV id="navigation"><UL><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Tour" class="tour nav-item" id="tour">Tour</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Project" class="project nav-item active" id="project">Project</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Results" class="results nav-item" id="results">Results</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Practices" class="pp nav-item" id="pp">P&amp;P</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Team/ATOMs" class="team nav-item" id="team">Team</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Extras" class="extras nav-item" id="extras">Extras</A></LI></UL></DIV></DIV><DIV id="sub-navigation-wrapper"><DIV id="sub-navigation"><UL id="project-sub" style="padding-right:350px"><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Project/Problems" class="sub-nav-item">Problems</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Project/Ulcer" class="sub-nav-item">Ulcer</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Project/Cancer_Switch" class="sub-nav-item">Cancer Switch</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Project/Modeling" class="sub-nav-item">Modeling</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Project/Safety" class="sub-nav-item">Safety</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Project/Future_Plan" class="sub-nav-item">Future Plan</A></LI></UL><UL id="team-sub"><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Team/ATOMs" class="sub-nav-item">ATOMs</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Attributions" class="sub-nav-item">Attributions</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Team/Collaboration" class="sub-nav-item">Collaboration</A></LI></UL><UL id="extras-sub"><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Extras/Notebook" class="sub-nav-item">Notebook</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Extras/Protocols" class="sub-nav-item">Protocols</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Extras/Achievements" class="sub-nav-item">Achievements</A></LI><LI><A href="http://parts.igem.org/cgi/partsdb/pgroup.cgi?pgroup=iGEM2015&amp;group=ATOMS-Turkiye" class="sub-nav-item">Official Part Page</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Team/Interlab_Study" class="sub-nav-item">Interlab Study</A></LI></UL><UL id="pp-sub" style="padding-right:60px"><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Practices/Virtual_Hospital" class="sub-nav-item">Virtual Hospital</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Practices/Video" class="sub-nav-item">Video</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Practices/SynBio_Day" class="sub-nav-item">SynBio Day</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Practices/Outreach" class="sub-nav-item">Outreach</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Practices/Street_Interview" class="sub-nav-item">Street interview</A></LI><LI><A href="https://2015.igem.org/Team:ATOMS-Turkiye/Practices/Ethics" class="sub-nav-item">Ethics</A></LI></UL></DIV></DIV></DIV><DIV id="footer"><DIV id="footer-content"><H2>Team ATOMS-Turkiye</H2><H3>atoms2015@googlegroups.com</H3></DIV></DIV><DIV id="page-wrapper"><DIV class="main"><ARTICLE class="post__article"><DIV id="content-div" style="height:200px; background-image:url(https://static.igem.org/mediawiki/2015/a/ab/ATOMS-Turkiye_picture_1.jpg); padding-bottom:0px; background-size:cover"><H1>FUTURE</H1></DIV><DIV id="content-div"><H3>Future Plan</H3><P>In our project, we have expected to resolve gastric ulcer disease and gastric cancer. We have told that the virulence of pathogenic bacteria Helicobacter 

pylori occurs gastric ulcer. Also we have told Gastric cancer is the uncontrolled 

cell division and cumulative results of genetic mutations in this region. We have 

aimed in our project eradication with Acid resistance, flagella expedite, 

chemotaxis to h.pylori with sensing Al2 and NH3, DAMP-Pexiganan produce and 

Pexiganan activator TEV Protease features(modifications) added E.coli. In our 

gastric cancer module we have expected hBAX apoptotic protein production in 

cancer cells within sensing excessive increased and decreased microRNA levels 

,if we compare with normal cells, and matching right cancer situation profile 

with our genetic circuit detection system. So our expectation was create the 

target-driven chemotherapy treatment that do not damaging normal cells and 

kill target cancer cells efficiency. In case of these, in these methods performing 

synthetic biology have a substantial role. But we can not ignore present's some 

problems beside that situation. Some of these are gene therapy's level of 

security, deprivation of medication etc. In addition to these problems there are 

some necessaries what support we have to do this, if we set an exemple; At the 

present, tetra-medication method is using for ulcer treatment. And these four 

drugs' three of them are antibiotics to kill helicobacter pylori. But in the future 

antibiotic resistance may develop in h.pylori to these antibiotics. Consequently 

tetra-medication method usebility may be hard at the future. Unfortunately, 

about cancer there are not any advenced clear treatment at the present. So that 

at the future time we will benefit from synthetic biology without pass by safety 

and ethic problems for eleminating these all of the problems. Nowadays we 

expect our developed treatment methods will rank as modern treatment 

methods if we do not encounter a problem.

Our treatment will be done with three stages;</P><P>1)Diagnosis and recognition

People who have gastric diseases will diagnose with routin ways or more 

sensitive effective ways which may discover at the future. After the diagnosis of 

cancer or stomach ulcer in patients our treatment methods will performed. Our 

curative E.coli will given in a capsule as like a drug. Or our genetic circuit will 

given in liposomes or exosomes by intraveneous way.</P><P>2)Monitoring treatment developing

Inferentially one week later from our treatments' using. Patients' recovery 

amount will detect with a contol testing like stomach screening. To redetermine 

treatment dosage and treatment's continue or not this part is necessary. 

Especially for cancer module this part is very important. Because treatment 

length will change within these treatment screening and monitoring.</P><P>3)Being finished of treatment

Treatment will be terminated if it is complately heal would detect after the 

controlls at regular intervals to the patient. But before leaving the patient's 

treatment use, you must go to the doctor for a final time check whether to learn 

are there is any risk factor beside. After this phase we will conclude that the 

patient is now healed. Also at the future ethics also can be encountered any 

problems in areas such as like as safety subjects. In this case, used treatment may 

have to be revised again according to the conditions of time.</P></DIV></ARTICLE></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>